Wednesday, October 7, 2026

SWIM Women's Entrepreneur Success Club: From Credit to Capital launches purpose-before-product education for women entrepreneurs

SWIM Women's Entrepreneur Success Club: From Credit to Capital launches purpose-before-product education for women entrepreneurs
SWIM’s purpose-before-product framework asks women entrepreneurs to define what capital is expected to accomplish before evaluating financing. The book encourages consideration of cost, repayment, business economics and downside risk before a funding decision is made.
SWIM’s new education series teaches women entrepreneurs to define business purpose, economics and repayment responsibilities before evaluating potential financing.

NEW YORK, NY - October 07, 2026 - SWIM — Successful Women Investing Money — is introducing a purpose-before-product educational initiative based on SWIM: From Credit to Capital, helping women entrepreneurs and women-owned businesses evaluate why capital may be needed before considering how it might be obtained.

The initiative is being developed with Cyra Gish, SWIM New York Chapter President and co-author of the book.

Additional information about Gish, SWIM and business-capital discussions is available at https://nationwidebusinessfunding.com/cyrag.

The educational premise is simple: the purpose comes first, and the financing product follows the strategy.

Different objectives require different questions

Business owners seek capital for different reasons.

A company may need equipment to increase production, inventory to meet demand, marketing to acquire customers, working capital to manage timing or financing connected to an acquisition or qualifying real estate.

Those objectives are not interchangeable.

Each may involve different risks, timelines and financing structures.

SWIM therefore encourages entrepreneurs to define the commercial objective before evaluating potential financing.

“The first question is not simply how much money may be available,” Gish said. “The first question is what the business is trying to accomplish and whether the economics justify the obligation.”

Five questions frame the discussion

The From Credit to Capital framework asks entrepreneurs to consider five fundamental questions.

What will the capital do?

What will it cost?

What repayment obligation will it create?

What must happen for the proposed deployment to succeed?

What happens if the expected result takes longer or produces less than projected?

Those questions move the financing discussion from availability toward responsibility.

Nationwide Business Funding supports comparison

Gish works with Nationwide Business Funding, which helps qualified businesses evaluate potential financing categories through independent providers.

The process may include identifying the objective, mapping potential provider categories, comparing structures and considering the timing of financing decisions.

Nationwide Business Funding does not control independent provider approvals or terms.

Financing availability depends on the provider, business, applicant and transaction.

SWIM participation remains separate from the Nationwide Business Funding relationship.

Capital can amplify strong and weak decisions

SWIM teaches that outside capital is neither automatically beneficial nor automatically harmful.

Its effect depends partly on what the business does with the resources.

Capital deployed within a sound strategy may increase capacity.

Capital deployed into an objective without sufficient economics or execution may increase obligations without producing the intended result.

That is why the book treats capital deployment as a separate discipline from capital access.

Financial independence includes the ability to decline

The initiative also emphasizes that financial judgment can include declining financing that does not fit.

A business owner may determine that an opportunity should be delayed, reduced, funded differently or not pursued.

SWIM presents the ability to say no as part of responsible financial decision-making.

The educational goal is not maximum borrowing.

It is better judgment.

The book expands the framework

SWIM: From Credit to Capital develops the purpose-before-product concept across entrepreneurship, capital strategy, corporate structure, ownership, acquisitions, real estate, operating infrastructure and financial wellness.

The book is expected to be available on Amazon.

Additional publication information will also be available through Gish’s page.

Frequently Asked Questions

Does SWIM recommend one financing product?No.

Does available financing mean it should be accepted?No.

Who determines financing terms?Independent providers.

Where will the book be available?Amazon and through information on Cyra Gish’s page.

About SWIM

SWIM — Successful Women Investing Money — is a women-centered entrepreneurship, capital and ownership community. Its educational framework connects financial preparation, business purpose, ownership and operating infrastructure with long-term financial choice.

About Nationwide Business Funding

Nationwide Business Funding helps qualified businesses evaluate potential financing pathways through independent providers. Provider underwriting, approval and terms remain independent.

Media Contact
Company Name: Nationwide Business Funding a Div. of LMT
Contact Person: Nationwide Business Funding
Email:Send Email
Phone: 1 (888) 599-8038
Address:1000 Brickell Ave
City: Miami
State: FL
Country: United States
Website: https://www.nationwidebusinessfunding.com

Ventura County Kitchens Explains Which Kitchen Upgrades Can Make the Biggest Difference in Everyday Functionality

Ventura County Kitchens Explains Which Kitchen Upgrades Can Make the Biggest Difference in Everyday Functionality
Ventura County Kitchens is helping Camarillo homeowners identify kitchen upgrades that can have the greatest impact on everyday functionality. Owner Eric Cooper highlights efficient layouts, improved cabinetry and storage, usable countertop space, better lighting, durable surfaces, and carefully planned work zones as priorities that can make kitchens more practical without focusing solely on cosmetic changes.

Camarillo, CA - October 7, 2026 - A kitchen renovation does not necessarily need to change every feature in the room to make a meaningful difference in how the space functions. Ventura County Kitchens is highlighting several upgrades Camarillo homeowners can consider when the goal is to improve everyday cooking, storage, organization, and movement rather than simply update the kitchen's appearance.

Owned by Eric Cooper, Ventura County Kitchens provides kitchen remodeling services in Camarillo and surrounding Ventura County communities. The company specializes in Kitchen Remodel, Kitchen Design, Cabinet Installation, and Backsplash Installation, helping homeowners develop renovation plans around the way their households actually use the kitchen.

According to Cooper, one of the most important places to begin is the layout. Homeowners can evaluate how frequently they move between the refrigerator, sink, cooking area, countertops, pantry, and storage during a typical day. Unnecessary movement, restricted walkways, poorly positioned appliances, or limited preparation space can make even an attractive kitchen inconvenient to use.

“The upgrades that make the biggest difference are often the ones homeowners notice every day after the project is finished,” said Eric Cooper, owner of Ventura County Kitchens. “Good storage, enough workspace, practical lighting, and a layout that makes sense for the household can be just as important as the finishes people see first.”

Thoughtful Kitchen Design can address these issues by considering how individual elements work together. A renovation plan may involve repositioning certain features, but improving functionality does not automatically require completely changing the room's footprint. In some kitchens, relatively focused changes can improve movement and make better use of existing space.

Cabinetry is one area where those changes can have a substantial impact. Traditional shelves may leave items difficult to reach or create unused space, while drawers, pull-out storage, vertical dividers, pantry organizers, and other configurations can make frequently used items more accessible.

For homeowners considering Cabinet Installation, planning the interior storage can be just as important as selecting the door style or finish. Pots, pans, dishes, food, small appliances, recycling, and cleaning supplies have different storage requirements. Designing cabinetry around those needs can reduce countertop clutter and make the kitchen easier to organize.

Usable countertop space is another important consideration. A kitchen may technically have substantial counter area while still lacking convenient preparation space because of appliance placement, sinks, corners, or frequently stored items.

Homeowners can evaluate where they prepare meals, unload groceries, use small appliances, and serve food. Islands and peninsulas can add useful workspace when the room has sufficient clearance, but they should be sized and positioned so they improve rather than restrict circulation.

Lighting can also change how effectively a kitchen functions. General ceiling lighting may illuminate the room without adequately lighting countertops and other work areas. Combining ambient lighting with task lighting near preparation areas, sinks, and cooking surfaces can make the room more practical throughout the day.

Electrical planning often goes hand in hand with these decisions. The location of outlets, appliances, charging areas, and lighting controls can be considered during the broader remodeling process rather than treated as an afterthought.

Backsplashes provide another opportunity to combine function and appearance. A professionally planned Backsplash Installation can protect wall surfaces in frequently used areas while contributing to the overall design. Tile dimensions, grout, pattern, material, and ease of cleaning can be evaluated alongside cabinetry and countertops so the finished elements work together visually.

Durability should also influence material selection. Kitchens regularly encounter spills, heat, moisture, cleaning, and heavy use. Countertops, flooring, cabinet finishes, hardware, and backsplashes can therefore be evaluated not only for appearance but also for the amount of maintenance they require and how they fit the household's daily routine.

Another functional priority is creating defined zones within the kitchen. Food preparation, cooking, cleanup, beverage preparation, storage, and seating do not necessarily need to occupy separate rooms, but thinking of them as distinct activity areas can help homeowners determine where specific cabinets, appliances, and work surfaces should be located.

For households where more than one person regularly uses the kitchen, circulation becomes particularly important. Appliance doors, cabinet doors, seating, and walkways should be considered together so normal activities do not repeatedly interfere with one another.

Homeowners should also think about how the kitchen connects to adjacent living and dining areas. Some Camarillo properties may benefit from a more open relationship between spaces, while others may function better by preserving separation and concentrating improvements within the existing kitchen footprint. There is no single layout that works for every home.

A complete Kitchen Remodel provides an opportunity to evaluate these elements as one coordinated system. Changing cabinetry may affect countertops and backsplashes, moving appliances can affect electrical or plumbing requirements, and altering an island can influence lighting and circulation.

For that reason, Ventura County Kitchens recommends identifying the kitchen's biggest functional frustrations before selecting individual finishes. Homeowners can make a list of what is difficult to store, where additional workspace is needed, which areas feel crowded, and what tasks are inconvenient in the existing layout.

Those priorities can then help guide the remodeling budget. Instead of distributing resources evenly across every feature, homeowners can focus first on improvements that address the problems affecting everyday use and then evaluate cosmetic upgrades within the remaining project scope.

Long-term usability is another consideration. Household routines can change over time, so accessible storage, comfortable clearances, durable materials, adequate lighting, and flexible work surfaces can help a remodeled kitchen remain practical beyond current design trends.

Ventura County Kitchens emphasizes that functionality and appearance do not need to compete with each other. A well-planned renovation can coordinate cabinetry, surfaces, lighting, storage, and finishes while still focusing on how the kitchen performs as an everyday working space.

For Camarillo homeowners considering a kitchen renovation, evaluating these functional priorities before construction begins can provide a clearer framework for design decisions and help ensure that individual upgrades contribute to the overall room.

Ventura County Kitchens continues to help homeowners throughout Camarillo and surrounding Ventura County communities plan kitchen renovations around layout, storage, usability, materials, and individual design preferences.

Homeowners interested in improving an existing kitchen can contact Ventura County Kitchens in Camarillo, California to discuss kitchen design, cabinetry, backsplash, and remodeling options.

About Ventura County Kitchens

Ventura County Kitchens is a kitchen remodeling company serving Camarillo, California and surrounding Ventura County communities. Owned by Eric Cooper, the company specializes in kitchen remodel, kitchen design, cabinet installation, and backsplash installation services for residential properties.

Media Contact
Company Name: Ventura County Kitchens
Contact Person: Eric Cooper
Email:Send Email
Phone: 805-694-4950
Address:1905 Daily Dr
City: Camarillo
State: CA
Country: United States
Website: https://www.venturacountykitchens.info/

Hustlepedia.store Expands AI-Powered Business Platform to Help Entrepreneurs Build, Create and Launch Faster

Hustlepedia.store Expands AI-Powered Business Platform to Help Entrepreneurs Build, Create and Launch Faster
“AI is changing how businesses are built, marketed, and operated, but many entrepreneurs still don’t know where to begin. We built Hustlepedia.store to make these new tools and opportunities easier to understand and actually use. Our goal is to help entrepreneurs move from idea to execution faster with practical resources they can start implementing immediately.”
Hustlepedia.store is expanding its growing library of practical, affordable resources built for entrepreneurs, content creators, and small business owners navigating the rapidly changing world of artificial intelligence. The platform provides actionable guides, digital toolkits, and business systems focused on AI-powered content creation, automation, digital marketing, AI influencers, online business models, and emerging opportunities entrepreneurs can put into action quickly.

Houston, Texas, United States of America — October 7, 2026 — Hustlepedia.store, a digital business resource platform operated by Hustlepreneur, LLC, is expanding its collection of tools, guides, and digital resources designed to help entrepreneurs take advantage of the rapidly evolving opportunities created by artificial intelligence.

As AI continues to transform content creation, marketing, automation, ecommerce, and online business, entrepreneurs are gaining access to capabilities that were once available primarily to larger companies with dedicated teams and significant budgets. Hustlepedia.store aims to help make those capabilities easier to understand, access, and implement.

The platform is built for entrepreneurs, content creators, side hustlers, and small business owners who want to use AI to move faster without becoming overwhelmed by complicated technology, expensive consulting programs, or enterprise-level software.

Rather than focusing heavily on theory, Hustlepedia.store emphasizes practical execution. Its resources are designed to help users understand how emerging tools can be applied to real-world business activities such as creating content, developing digital products, building online brands, automating repetitive tasks, marketing products, launching AI-powered creators, and identifying new business opportunities.

One of the platform’s expanding areas of focus is AI-powered content creation.

Entrepreneurs increasingly rely on social media, short-form video, product content, email marketing, and digital storytelling to reach customers. Hustlepedia.store provides resources designed to help users incorporate artificial intelligence into these processes, allowing individual creators and small business owners to produce more content while reducing the amount of time required to create it.

The company is also developing resources around the growing AI influencer and virtual creator economy.

AI-generated personalities are increasingly being used for content creation, product promotion, user-generated-content-style marketing, social media campaigns, and brand development. Hustlepedia.store provides educational resources intended to help entrepreneurs understand how these digital personas can be created, positioned, grown, and potentially incorporated into modern marketing strategies.

Automation represents another major area of the platform’s expanding catalog.

For solo entrepreneurs, time is often one of the most limited resources. Hustlepedia.store focuses on helping users identify ways AI tools and automated workflows can reduce repetitive work across marketing, content development, research, planning, and day-to-day business operations.

The platform also explores emerging online business models made possible or accelerated by artificial intelligence.

These include AI-assisted digital products, content businesses, creator brands, automation services, AI-supported ecommerce, virtual influencers, and other evolving opportunities that allow entrepreneurs to build businesses with smaller teams and more efficient workflows.

Hustlepedia.store was created around a simple idea: entrepreneurs should not need a large budget, technical background, or expensive consultant to begin experimenting with emerging business technology.

While information about artificial intelligence is widely available, it is often scattered across social media posts, videos, software documentation, and highly technical resources. Hustlepedia.store aims to organize that information into practical, focused resources entrepreneurs can use to move from learning to implementation.

The platform offers both paid and complimentary resources, allowing visitors to explore its educational approach before purchasing larger toolkits and business systems.

Free resources are used as an entry point for entrepreneurs who want to experiment with new strategies without a major upfront investment. Hustlepedia.store plans to continue expanding these offerings as new AI tools, platforms, and online business opportunities emerge.

The company’s broader strategy reflects a shift in how entrepreneurs are learning to build businesses.

Instead of relying exclusively on lengthy courses, traditional consulting, or formal business programs, many entrepreneurs are seeking focused resources that can help them solve a specific problem, launch an idea, or implement a new strategy quickly.

Hustlepedia.store is designed around that shift.

Resources are structured so users can access them on demand, work through them at their own pace, and apply the concepts directly to their businesses, brands, or content projects.

The platform’s growing catalog is expected to continue expanding alongside developments in artificial intelligence and the creator economy. Future resources are planned around AI tools, automation, content monetization, digital product creation, emerging online business models, marketing systems, and other areas where new technology is creating opportunities for independent entrepreneurs.

Customer feedback and market trends will also help shape future releases, allowing Hustlepedia.store to focus on areas where entrepreneurs are actively looking for practical guidance.

Accessibility remains a central part of the company’s approach.

Hustlepedia.store aims to provide professional-quality business resources at price points that are realistic for solo entrepreneurs, creators, and small business owners who may not have the budgets associated with traditional agencies, consultants, or business coaching programs.

As artificial intelligence continues to reshape entrepreneurship, Hustlepedia.store intends to position itself as a practical starting point for people who want to understand what is changing, identify where opportunities may exist, and begin putting those ideas into action.

ABOUT HUSTLEPEDIA.STORE

Hustlepedia.store is a digital business resource platform operated by Hustlepreneur, LLC. The platform provides practical guides, digital toolkits, and educational resources for entrepreneurs, content creators, side hustlers, and small business owners.

Hustlepedia.store focuses on AI-powered business creation, content development, automation, digital marketing, AI influencers, online business models, digital products, and emerging opportunities created by new technology.

Through a combination of free and paid resources, Hustlepedia.store aims to help entrepreneurs understand new tools, identify opportunities, and move from idea to execution faster without the cost or complexity of traditional consulting and business education.

CONTACT: https://hustlepedia.store/

https://www.facebook.com/share/1ExcYnvdzq/?mibextid=wwXIfr

https://www.tiktok.com/@hustlepedia.store?_r=1&_t=ZT-9AFrOOX9sar

https://www.tiktok.com/@hustlepedia.store?_r=1&_t=ZT-9AFrOOX9sar

Media Contact
Company Name: Hustlepedia.store
Contact Person: Sky DeJohn
Email:Send Email
Country: United States
Website: https://hustlepedia.store/

Lewis Water Restoration Explains What Property Owners Should Check After Recent Heavy Rain and Northeast Storm Conditions

Lewis Water Restoration Explains What Property Owners Should Check After Recent Heavy Rain and Northeast Storm Conditions
Lewis Water Restoration is encouraging Paterson property owners to check for hidden moisture following recent heavy rain and strong winds in North Jersey. Founded in 2012, the company highlights basements, walls, ceilings, flooring, plumbing, and other vulnerable areas where water intrusion may not be immediately visible, along with warning signs that can indicate developing water or mold problems.

Paterson, NJ - October 7, 2026 - Following a stretch of significant September weather in North Jersey, Lewis Water Restoration is encouraging Paterson property owners to check homes and businesses for signs of water intrusion and lingering moisture. The National Weather Service issued flood-related alerts for eastern Passaic County during heavy rainfall in September, and Paterson was also under a Wind Advisory during the late-September nor’easter, making early October a timely opportunity to examine areas where storm-related moisture may not be immediately visible.

Founded in 2012 and owned by Jayden Cox, Lewis Water Restoration provides property restoration services in Paterson and surrounding North Jersey communities. The company specializes in Water Damage Restoration, Fire Damage Restoration, Mold Remediation, and Burst Pipe Repair, helping property owners respond to damage caused by water, moisture, plumbing failures, and other property emergencies.

One of the first places property owners should check after periods of heavy rain is the basement or lowest level of the building. Water can enter through vulnerable foundation areas, basement windows, exterior openings, drainage problems, or other pathways. Even when standing water is not present, damp walls, staining, peeling finishes, unusual odors, or changes in flooring can indicate that moisture entered the structure.

“Water damage is not always as obvious as a flooded room,” said Jayden Cox, owner of Lewis Water Restoration. “After significant rainfall, property owners should pay attention to smaller changes such as staining, damp materials, musty odors, or flooring that begins to look or feel different. Finding the source of moisture early can help determine what needs to be addressed.”

The recent weather provides a relevant reminder for North Jersey. On September 13, the National Weather Service reported flash flooding in eastern Passaic County after heavy rainfall, with radar and automated gauges indicating between one and 2.5 inches had already fallen in the warned area at one point. Later in the month, another storm brought rain and strong winds to the Paterson area, with the National Weather Service forecasting wind gusts as high as 40 mph on September 27.

Following substantial rainfall, professional Water Damage Restoration may involve more than removing visible water. The affected materials and the path the water traveled also need to be considered. Drywall, insulation, flooring, subflooring, cabinetry, and other porous materials can retain moisture even after exposed surfaces appear dry.

Ceilings and upper walls should also be checked. Roof or flashing problems can allow rainwater to enter higher portions of a building before moisture eventually becomes visible indoors. Discoloration, bubbling paint, softened drywall, or new stains can warrant further investigation.

Windows and exterior doors represent additional areas to examine. Property owners may notice staining around frames, damp trim, deteriorated sealant, or moisture along nearby flooring following wind-driven rain.

Another concern is moisture that remains trapped long enough to create conditions favorable to microbial growth. Mold Remediation may become necessary when mold growth is identified and the underlying moisture source has been addressed. Simply cleaning a visible surface without determining why it became damp can leave the original problem unresolved.

Musty odors can be an important warning sign, particularly in basements, closets, wall cavities, utility areas, and rooms that receive limited airflow. A persistent odor does not by itself identify the source, but it can indicate that an area warrants closer evaluation.

Property owners should also distinguish storm-related water entry from plumbing problems. A damp wall, ceiling stain, or wet floor can sometimes result from a leaking supply line, drain, appliance connection, or another plumbing component rather than exterior rainfall.

This becomes increasingly relevant as New Jersey moves toward colder weather. Plumbing systems located in vulnerable or inadequately protected areas can face additional challenges as temperatures decline. Professional Burst Pipe Repair may be required when a pipe fails and releases water into walls, ceilings, floors, basements, or other areas of a property.

Knowing the location of the property's main water shutoff can be useful before an emergency occurs. If a significant plumbing leak develops, stopping the water supply when it is safe and practical to do so can help limit continued water release while professional assistance is arranged.

Businesses and commercial property owners should perform similar checks following severe weather. Storage areas, mechanical rooms, basements, roof penetrations, ceiling tiles, exterior walls, and areas around doors and windows can reveal evidence of water entry.

Documentation can also be valuable. Photographing visible damage and noting when moisture or staining first appeared can help property owners maintain a clearer record of the incident and subsequent restoration work.

Although water-related issues are a major focus following storms, restoration planning can involve other types of property damage as well. Fire Damage Restoration can require assessment of fire-affected materials along with smoke, soot, odors, and water introduced during firefighting efforts. Each type of loss requires evaluation based on the materials and areas actually affected.

Lewis Water Restoration emphasizes that property owners should avoid assuming a building is completely dry simply because visible water has disappeared. Moisture can migrate beneath flooring, behind walls, into insulation, and through other concealed building materials.

At the same time, evidence of moisture does not automatically mean extensive restoration is required. The appropriate response depends on where the water originated, how much entered the property, how long materials remained wet, and which components were affected.

For Paterson homeowners and businesses, early October provides a useful opportunity to check properties following September's periods of heavy rainfall and strong winds while also preparing for colder weather ahead.

Lewis Water Restoration continues to help residential and commercial property owners throughout Paterson and surrounding North Jersey communities evaluate water-related property damage and determine appropriate drying, restoration, and remediation options.

Property owners who discover unexplained moisture, staining, water damage, mold concerns, or plumbing-related damage can contact Lewis Water Restoration in Paterson, New Jersey for a professional property evaluation.

About Lewis Water Restoration

Lewis Water Restoration is a property restoration company based in Paterson, New Jersey. Founded in 2012 and owned by Jayden Cox, the company specializes in water damage restoration, fire damage restoration, mold remediation, and burst pipe repair for residential and commercial properties in Paterson and surrounding North Jersey communities.

Media Contact
Company Name: Lewis Water Restoration
Contact Person: Jayden Cox
Email:Send Email
Phone: 973-899-9030
Address:277 Main St Ste 1
City: Paterson
State: NJ
Country: United States
Website: https://www.lewiswaterrestoration.com/

Reverse Mortgage Requirements in Canada: New Guide Sets Out Who Qualifies

Reverse Mortgage Requirements in Canada: New Guide Sets Out Who Qualifies
A new guide lists the reverse mortgage requirements in Canada in full, and explains why the two things most homeowners worry about, income and credit, are not the deciding factors.

HAMILTON, Ontario - October 7, 2026 - The reverse mortgage requirements in Canada are shorter than most homeowners expect, according to a new guide published by an independent Ontario mortgage brokerage for homeowners aged 55 and over.

The requirements for a reverse mortgage come down to three things. Every owner on title must be 55 or older. The home must be the borrower's primary residence. And the property's type, value and location must meet the lender's rules.

What is absent from that list is the part that stops most people from asking. There is no income qualification of the kind a bank applies, and no stress test. Approval rests mainly on age, the home's value and where it is. Credit is reviewed, but it does not work the way it does on a conventional mortgage application.

"People talk themselves out of this before they ask. They assume their pension is too small or their credit is too marked up. Neither is the test," said Richard Hopkins, Mortgage Broker, licence M16000896.

The guide answers the questions homeowners raise most often about reverse mortgage eligibility:

Do condominiums qualify? Yes. So do detached homes, semis and townhouses. Lenders assess the individual unit's value, the building and the location.

What if there is still a mortgage on the home? An existing mortgage or home equity line of credit does not disqualify anyone. It is paid off and closed from the proceeds, and that is the single most common use of a reverse mortgage in Canada.

Does both spouses' age matter? Every owner on title must meet the minimum age, so the younger spouse usually sets the amount available. One lender's rules differ on whose name must be on title, which can change the outcome on the right file, and the guide explains when that is worth exploring.

How much does meeting the requirements unlock? Homeowners typically access a fifth to over half of the home's value, with the share rising by age and the market's top tier reserved for older borrowers.

Can an application be declined? Yes. The guide is direct about the property types and situations that lenders turn down, so homeowners can find that out before an appraisal is paid for.

Ontario requires every reverse mortgage borrower to receive independent legal advice from their own lawyer before closing, which is a requirement of the transaction rather than of qualifying.

The guide is written by Richard Hopkins, a Mortgage Broker (licence M16000896) with Dominion Lending Centres Homestead Financial, an independent Ontario brokerage licensed by the Financial Services Regulatory Authority of Ontario (brokerage licence #11711). It is free to read at:

https://reversemortgagebroker.ca/reverse-mortgage-requirements/?utm_source=abnewswire&utm_medium=press_release&utm_campaign=pr07-requirements

Homeowners can check what they qualify for with a free estimate, with no credit check and no sales pressure.

About Dominion Lending Centres Homestead Financial

Dominion Lending Centres Homestead Financial is an independent mortgage brokerage in Hamilton, Ontario, licensed by the Financial Services Regulatory Authority of Ontario (brokerage licence #11711) and in business since 1999. More than 1,200 Ontario families have arranged a mortgage through the brokerage. Independently Owned and Operated. Richard Hopkins, Mortgage Broker (licence M16000896), leads its reverse mortgage practice.

Media Contact
Company Name: Homestead Financial
Contact Person: Richard Hopkins
Email:Send Email
Phone: 905-690-6068
Address:26 Glaceport Ave
City: Dundas
State: Ontario
Country: Canada
Website: https://reversemortgagebroker.ca/reverse-mortgage-requirements/?utm_source=abnewswire&utm_medium=press_release&utm_campaign=pr07-requirements

Diabetic Macular Edema Market is Projected to Grow by 2036 Owing to Rising Diabetes Burden and Advancements in Long-Acting Retinal Therapies | DelveInsight

Diabetic Macular Edema Market is Projected to Grow by 2036 Owing to Rising Diabetes Burden and Advancements in Long-Acting Retinal Therapies | DelveInsight
The market dynamics for Diabetic Macular Edema are witnessing steady growth driven by the increasing prevalence of diabetes, growing disease burden, improvements in retinal screening and diagnosis, continued dominance of anti-VEGF therapies, and increasing adoption of long-acting and sustained-delivery treatments. The treatment landscape is also expanding beyond conventional VEGF inhibition, with emerging therapies targeting novel biological pathways and alternative routes of administration.

(Albany, New York) – October 07, 2026 - The market dynamics for Diabetic Macular Edema (DME) are witnessing steady growth driven by the increasing prevalence of diabetes, growing disease burden, improvements in retinal screening and diagnosis, continued dominance of anti-VEGF therapies, and increasing adoption of long-acting and sustained-delivery treatments. The treatment landscape is also expanding beyond conventional VEGF inhibition, with emerging therapies targeting novel biological pathways and alternative routes of administration. The development of therapies such as OCS-01, RG6351, and Restoret (MK-3000) is expected to further reshape the DME market by addressing treatment durability, injection burden, and inadequate response to existing therapies.

DelveInsight, a leading market research firm, announces the release of its latest report, “DelveInsight’s Diabetic Macular Edema (DME) Market Insights, Epidemiology, and Market Forecast – 2036.” The report provides an in-depth assessment of the DME market, including historical and forecasted epidemiology, treatment practices, emerging therapies, market dynamics, competitive landscape, and growth opportunities across the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.

Key Takeaways from the Diabetic Macular Edema Market Report

  • The 7MM Diabetic Macular Edema market was approximately USD 4,000 million in 2025 and is projected to grow at a 3.5% CAGR during 2026–2036.

  • The United States accounted for approximately USD 2,200 million in DME market size in 2025, representing the largest share among the 7MM.

  • The United States represented approximately 60% of the total 7MM DME market in 2025, followed by Germany and Japan.

  • The total diagnosed prevalent DME population across the 7MM was approximately 900,000 cases in 2025.

  • In the United States, DME prevalence was higher among males, at approximately 300,000 cases, compared with around 210,000 cases among females in 2025.

  • The 45–64 years age group accounted for approximately 224,000 DME cases in the United States in 2025, followed by individuals aged ≥75 years with approximately 220,000 cases.

  • Anti-VEGF therapies remain the backbone of DME treatment, with EYLEA, LUCENTIS, BEOVU, and VABYSMO among the major therapies used in clinical practice.

  • The treatment landscape is increasingly moving toward long-acting therapies, sustained drug delivery, biosimilars, and non-VEGF mechanisms to reduce injection frequency and improve treatment outcomes.

  • Key emerging therapies include OCS-01, RG6351, and Restoret (MK-3000).

  • Major companies active in the DME market include Regeneron Pharmaceuticals/Bayer, Genentech, Bayer, Roche, Novartis, Sandoz, Oculis, and Merck, among others.

Keen to know more about the market? Request our sample page athttps://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-market

Key Factors Driving the Diabetic Macular Edema Market

Rising Diabetes Burden and DME Patient Population

The increasing prevalence of Diabetes Mellitus is one of the fundamental factors supporting the expansion of the DME market. DME develops as a complication of diabetic retinopathy, with chronic hyperglycemia damaging retinal blood vessels and increasing vascular permeability. Poor glycemic control, longer duration of diabetes, hypertension, obesity, and population aging further contribute to the risk of developing DME. As the global diabetic population continues to expand, the addressable population requiring retinal screening, monitoring, and treatment is also increasing.

Increasing Adoption of Anti-VEGF Therapies

Anti-VEGF therapies have fundamentally changed DME management by reducing abnormal vascular permeability and improving retinal thickness and visual outcomes. Aflibercept, ranibizumab, brolucizumab, and faricimab form an important part of the current treatment landscape. Their established efficacy and widespread clinical adoption continue to support the commercial value of the DME market.

Shift Toward Long-Acting and Sustained-Delivery Treatments

The high frequency of intravitreal injections represents a significant burden for DME patients and healthcare providers. Consequently, the development of long-acting implants and sustained-delivery technologies is becoming increasingly important. SUSVIMO, a ranibizumab implant, represents an important advancement because it can provide sustained intraocular drug delivery and reduce the frequency of conventional injections.

Expansion of Biosimilars and Cost-Effective Treatment Options

The emergence of biosimilar therapies is expected to increase competition and potentially improve affordability and patient access. OPUVIZ (aflibercept-yszy) and ENZEEVU (aflibercept-abzv) are contributing to the expanding biosimilar landscape in retinal diseases, including DME. Greater availability of lower-cost alternatives could influence prescribing patterns and market access, particularly in cost-sensitive healthcare systems.

Emergence of Non-VEGF and Non-Invasive Therapies

The DME pipeline is increasingly moving toward mechanisms beyond conventional VEGF inhibition. Novel approaches include WNT pathway modulation, Tie-2 pathway activation, topical corticosteroid delivery, and gene-based approaches. Such therapies could be particularly valuable for patients who respond inadequately to anti-VEGF therapy or require more durable disease control.

Diabetic Macular Edema Competitive Landscape

The DME competitive landscape is highly dynamic, with established pharmaceutical companies competing across anti-VEGF therapies, corticosteroids, sustained-delivery systems, biosimilars, and emerging targeted treatments. Major companies identified by DelveInsight include Regeneron Pharmaceuticals/Bayer, Genentech, Bayer, Roche, Novartis, Sandoz, Oculis, and Merck.

Among marketed therapies, EYLEA (aflibercept) remains an important anti-VEGF therapy. It acts as a VEGF trap by binding VEGF-A, VEGF-B, and placental growth factor. EYLEA received US FDA approval for DME in 2014. LUCENTIS (ranibizumab), marketed by Genentech in the United States, is another established anti-VEGF treatment approved for DME.

VABYSMO (faricimab) introduced dual-pathway inhibition by simultaneously targeting VEGF-A and Ang-2, providing an additional mechanism for improving vascular stability and treatment durability. Meanwhile, BEOVU (brolucizumab) provides another anti-VEGF option with extended dosing potential.

The competitive environment is further intensifying with biosimilars and emerging long-acting formulations, which could influence pricing, accessibility, patient adherence, and market share over the forecast period.

Discover more about therapies set to impact the Diabetic Macular Edema market @Diabetic Macular Edema Treatment Landscape

Recent Developments in the Diabetic Macular Edema Market

  • April 2026: Regeneron Pharmaceuticals announced that the US FDA approved an extension of EYLEA dosing intervals to up to every 20 weeks for patients with wet age-related macular degeneration and DME following one year of successful response.

  • February 2026: Sandoz announced US FDA approval of an expanded label for ENZEEVU, adding retinal indications including diabetic retinopathy and DME, alongside its previously approved indication for neovascular age-related macular degeneration.

  • February 2025: Roche received US FDA approval for ranibizumab implant (SUSVIMO) for DME, providing a long-acting ocular treatment option designed to reduce treatment frequency compared with conventional monthly injections.

  • September 2025: Oculis presented expanded analyses from the Phase III DIAMOND program evaluating OCS-01 eye drops in DME at the EURETINA Congress.

  • April 2025: Oculis announced completion of enrollment in the DIAMOND-1 and DIAMOND-2 Phase III trials of OCS-01 in DME, with topline data anticipated in the second quarter of 2026 and a planned US FDA NDA submission in the fourth quarter of 2026.

  • May 2024: Merck announced its acquisition of EyeBio, obtaining rights to Restoret (MK-3000), an investigational WNT pathway agonist being developed for DME and neovascular age-related macular degeneration.

What is Diabetic Macular Edema?

Diabetic Macular Edema (DME) is a vision-threatening complication of diabetic retinopathy characterized by the accumulation of fluid within the macula due to leakage from damaged retinal blood vessels. The resulting retinal thickening can impair central vision and, if inadequately managed, lead to significant visual impairment. DME is an important cause of vision loss among working-age adults.

Chronic hyperglycemia damages the blood-retinal barrier and increases vascular permeability, promoting fluid accumulation in the macular region. The increasing prevalence of diabetes, together with aging populations, sedentary lifestyles, and obesity, is contributing to the broader disease burden.

Diagnosis generally involves clinical retinal examination and imaging. Optical coherence tomography (OCT) is a key diagnostic tool for identifying retinal thickening and fluid accumulation, while fluorescein angiography may be used to assess vascular leakage and retinal perfusion.

DME can be classified into center-involved DME (CI-DME), where the fovea is affected, and non-center-involved DME (NCI-DME), where the central macula is spared.

Diabetic Macular Edema Epidemiology Segmentation

DelveInsight's epidemiological assessment of DME includes:

  • Total prevalent cases

  • Total diagnosed prevalent cases

  • Gender-specific diagnosed prevalent cases

  • Age-specific diagnosed prevalent cases

  • Subgroup-specific diagnosed prevalent cases

  • Total treated cases

According to DelveInsight estimates, the total diagnosed prevalent DME population across the 7MM was approximately 900,000 cases in 2025.

In the United States, approximately 300,000 DME cases were observed among males compared with approximately 210,000 among females in 2025. The 45–64 years age group represented the largest age category, with approximately 224,000 cases, followed by individuals aged ≥75 years, with approximately 220,000 cases.

Among the EU4 and the UK, Germany recorded the highest number of DME cases in 2025, followed by France, while Spain recorded the lowest number. Japan accounted for approximately 10% of the total diagnosed prevalent DME population across the 7MM in 2025.

Current Diabetic Macular Edema Treatment Landscape

The current DME treatment landscape is primarily dominated by intravitreal anti-VEGF therapies, which are considered first-line treatments because of their ability to reduce vascular leakage, retinal thickness, and vision loss. Key therapies include EYLEA, LUCENTIS, BEOVU, and VABYSMO.

Aflibercept (EYLEA) inhibits VEGF-A, VEGF-B, and placental growth factor and has been an important component of DME treatment since its FDA approval for the indication in 2014. Ranibizumab (LUCENTIS) is another established anti-VEGF therapy approved for DME in the United States.

Faricimab (VABYSMO) provides dual inhibition of VEGF-A and Ang-2 and has expanded the treatment paradigm toward improved vascular stability and potentially longer dosing intervals.

For patients with inadequate response to anti-VEGF therapy, corticosteroids can be used as second-line treatment. Dexamethasone and fluocinolone implants reduce inflammation and vascular leakage but may be associated with adverse effects including increased intraocular pressure and cataract formation.

Laser photocoagulation continues to have a role in selected patients, while advances in laser technologies are intended to improve treatment precision and reduce collateral retinal damage.

Unmet Needs in the Diabetic Macular Edema Market

Despite substantial advances, significant unmet needs remain in DME management. One of the most important challenges is the limited durability of existing anti-VEGF therapies, which can require repeated intravitreal injections over prolonged periods. This creates treatment burden for patients and healthcare providers and can contribute to adherence challenges.

A further unmet need is the management of anti-VEGF non-responders. A proportion of patients does not achieve adequate disease control with existing therapies, highlighting the need for alternative mechanisms of action. Long-acting and sustained-delivery approaches are therefore receiving increasing attention.

Other challenges include treatment-related adverse effects, high long-term treatment costs, access barriers, delayed diagnosis in asymptomatic patients, limited biomarker-driven treatment selection, recurrence, and the need for continuous monitoring.

The emergence of non-invasive and novel mechanism-based treatments could address several of these limitations and create new opportunities within the DME therapeutic market.

Scope of the Diabetic Macular Edema Market Report

The report covers the 2022–2036 study period, with 2022–2025 representing the historical period, 2026–2036 the forecast period, and 2026 the base year. The geographic scope includes the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.

The report provides comprehensive analysis of:

  • DME epidemiology and patient burden

  • Historical and forecasted market size

  • Current treatment practices and treatment algorithms

  • Marketed and emerging therapies

  • Drug uptake and patient-share analysis

  • Competitive landscape

  • Clinical trial developments

  • Market access and reimbursement

  • Pricing and analogue assessment

  • Key opinion leader insights

  • SWOT analysis

  • Conjoint analysis

  • Market drivers and barriers

  • Unmet medical needs

  • Future market opportunities

To know more about Diabetic Macular Edema companies, clinical trials, and therapeutic assessment, request a sample @Diabetic Macular Edema Market Report Sample

Table of Contents

  1. Key Insights

  2. Report Introduction

  3. Executive Summary

  4. Key Events

  5. Epidemiology and Market Forecast Methodology

  6. Diabetic Macular Edema Market Overview at a Glance

  7. Diabetic Macular Edema Disease Background and Overview

  8. Diabetic Macular Edema Epidemiology and Patient Population

  9. Diabetic Macular Edema Current Treatment Practices

  10. Diabetic Macular Edema Marketed Therapies

  11. Diabetic Macular Edema Emerging Therapies

  12. Diabetic Macular Edema Drug Analysis and Competitive Landscape

  13. Diabetic Macular Edema Market Outlook

  14. Diabetic Macular Edema Market Size and Forecast

  15. Diabetic Macular Edema Drug Uptake Analysis

  16. Diabetic Macular Edema Market Access and Reimbursement

  17. Diabetic Macular Edema Pricing and Analogue Assessment

  18. Diabetic Macular Edema Unmet Needs

  19. KOL Views and Expert Insights

  20. SWOT and Conjoint Analysis

  21. Market Drivers and Barriers

  22. Appendix

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in the life sciences and healthcare industries. Founded in 2014, the company provides comprehensive market intelligence, epidemiology, and insights across pharmaceuticals, biotechnology, medical devices, and emerging therapies. DelveInsight helps healthcare organizations make informed strategic decisions through data-driven research and industry expertise.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kirti Sharma
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Dravet Syndrome Market is Projected to Grow by 2036 Owing to Rising Diagnosis and Advancements in Gene-Targeted Therapies | DelveInsight

Dravet Syndrome Market is Projected to Grow by 2036 Owing to Rising Diagnosis and Advancements in Gene-Targeted Therapies | DelveInsight
The market dynamics for Dravet syndrome are witnessing steady growth, driven by increasing disease awareness, improvements in genetic testing and diagnosis, growing adoption of targeted anti-seizure therapies, and continued investment in precision and disease-modifying approaches. The therapeutic landscape is gradually shifting beyond conventional symptomatic seizure management toward treatments targeting the underlying SCN1A dysfunction.

(Albany, New York) – October 07, 2026 - The market dynamics for Dravet syndrome are witnessing steady growth, driven by increasing disease awareness, improvements in genetic testing and diagnosis, growing adoption of targeted anti-seizure therapies, and continued investment in precision and disease-modifying approaches. The therapeutic landscape is gradually shifting beyond conventional symptomatic seizure management toward treatments targeting the underlying SCN1A dysfunction. Additionally, the development of emerging therapies such as zorevunersen (STK-001), bexicaserin (LP352), clemizole hydrochloride (EPX-100), and ETX101 is expected to further transform the Dravet syndrome treatment landscape during the forecast period.

DelveInsight, a leading market research firm, announces the release of its latest report, “Dravet Syndrome Market Insights, Epidemiology, and Market Forecast – 2036.” The report provides an in-depth analysis of Dravet syndrome, including historical and forecasted epidemiology, existing treatment practices, emerging therapies, market trends, competitive dynamics, and growth opportunities across the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.

Key Takeaways from the Dravet Syndrome Market Report

  • The Dravet syndrome market is expected to expand at a healthy growth rate during 2026–2036, supported by the introduction of new therapies and an increasing diagnosed patient population. The public report page currently masks the numerical 2025 and 2036 market values and CAGR as XXX/XX%, so no numerical market estimate has been stated here.

  • The total diagnosed prevalent population of Dravet syndrome across the 7MM was approximately 25,600 cases in 2025.

  • The United States accounted for approximately 50% of diagnosed prevalent Dravet syndrome cases in the 7MM in 2025, representing the largest patient share among the covered markets.

  • The prevalence of Dravet syndrome has been estimated at approximately 1 in 20,000 to 1 in 40,000 individuals.

  • SCN1A mutations represent a major genetic feature of Dravet syndrome, with the report indicating that approximately 80–90% of cases are associated with mutations in the SCN1A gene.

  • Existing management includes combinations of fenfluramine, cannabidiol, stiripentol, valproate, and clobazam, together with trigger management, rescue medication, and long-term developmental and behavioral support.

  • Key marketed therapies include EPIDIOLEX/EPIDYOLEX (cannabidiol), FINTEPLA (fenfluramine), and DIACOMIT (stiripentol).

  • Prominent emerging therapies include zorevunersen (STK-001), bexicaserin (LP352), clemizole hydrochloride (EPX-100), and ETX101, reflecting growing development activity across antisense oligonucleotides, targeted small molecules, and gene therapy.

  • Major companies active in the Dravet syndrome treatment landscape include Stoke Therapeutics, Biogen, Longboard Pharmaceuticals, Harmony Biosciences, Encoded Therapeutics, Jazz Pharmaceuticals, UCB, Zogenix, and BIOCODEX, among others.

Keen to know more about the market? Request our sample page at:https://www.delveinsight.com/sample-request/dravet-syndrome-market

Key Factors Driving the Dravet Syndrome Market

The growing diagnosed patient population and improvements in disease recognition represent important factors supporting market development. Dravet syndrome is a rare developmental and epileptic encephalopathy that generally begins during infancy. Greater clinical awareness and increasing access to genetic testing are facilitating more accurate identification of patients, particularly those carrying disease-associated SCN1A mutations.

Another major growth factor is the transition toward precision and mechanism-based therapies. Existing treatments primarily focus on controlling seizures, whereas emerging approaches increasingly aim to address the molecular basis of the disease. Antisense oligonucleotides and gene-regulation therapies targeting SCN1A dysfunction could substantially alter the future treatment paradigm if their clinical development is successful.

The high unmet medical need is also encouraging continued pharmaceutical investment. Despite multiple anti-seizure therapies, many patients remain inadequately controlled, while cognitive, developmental, behavioral, and motor manifestations contribute significantly to long-term disease burden. Safety issues, treatment burden, heterogeneous response, and the absence of curative therapies continue to create opportunities for differentiated treatments.

Dravet Syndrome Competitive Landscape

The Dravet syndrome competitive landscape is evolving from established anti-seizure medications toward precision genetic therapies and targeted neuromodulators. Companies highlighted in DelveInsight's report include Stoke Therapeutics, Biogen, Longboard Pharmaceuticals, Harmony Biosciences, Encoded Therapeutics, Jazz Pharmaceuticals, UCB, Zogenix, and BIOCODEX, among others.

Among the prominent pipeline candidates, zorevunersen (STK-001) from Stoke Therapeutics and Biogen is an investigational antisense oligonucleotide designed to increase NaV1.1 protein expression by leveraging the functional copy of SCN1A. The report lists the candidate in Phase III development.

Bexicaserin (LP352) is listed as a Phase III oral small molecule targeting the serotonin 5-HT2C pathway, while clemizole hydrochloride (EPX-100) is another Phase III oral candidate acting through central serotonin receptors.

ETX101, being developed by Encoded Therapeutics, represents a different therapeutic strategy. It is an AAV9-based, cell-selective gene-regulation therapy designed as a potential one-time disease-modifying treatment for patients with SCN1A-positive Dravet syndrome. The DelveInsight report lists ETX101 in Phase I/II development.

Discover more about therapies set to impact the Dravet Syndrome market @Dravet Syndrome Treatment Landscape

Recent Developments in the Dravet Syndrome Market

  • In April 2026, Jazz Pharmaceuticals presented research concerning EPIDIOLEX (cannabidiol) Oral Solution in Dravet syndrome at the 2026 American Academy of Neurology Annual Meeting.

  • In March 2026, Stoke Therapeutics and Biogen reported clinical findings concerning zorevunersen from Phase I/IIa and extension-study evaluations, providing early evidence supporting its potential as a disease-modifying approach for Dravet syndrome.

  • In March 2026, Encoded Therapeutics announced completion of an RMAT meeting with the US FDA and alignment regarding the pivotal study design intended to support a future BLA submission for ETX101.

  • In January 2026, the development program for zorevunersen included the Phase III EMPEROR study, with the report noting plans for a mid-2027 data readout to support a rolling NDA submission.

  • In January 2026, the US FDA granted Breakthrough Therapy Designation to ETX101 for SCN1A-positive Dravet syndrome.

  • In December 2025, Encoded Therapeutics announced positive interim findings from the POLARIS clinical development program evaluating ETX101 in children with SCN1A-positive Dravet syndrome.

What is Dravet Syndrome?

Dravet syndrome, historically referred to as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare, lifelong developmental and epileptic encephalopathy that generally begins during infancy. Patients experience prolonged and frequently treatment-resistant seizures accompanied by developmental, cognitive, behavioral, motor, and speech-related complications.

Seizures typically begin during the first year of life and may initially be triggered by fever. A substantial proportion of Dravet syndrome cases are associated with mutations in the SCN1A gene, which encodes a voltage-gated sodium-channel protein involved in neuronal signaling. Because clinical manifestations evolve over time and can overlap with other childhood epilepsy syndromes, diagnosis can be challenging. Genetic testing for SCN1A mutations has therefore become an important component of diagnostic confirmation.

The disease requires lifelong multidisciplinary management, encompassing seizure control, emergency seizure management, developmental support, behavioral care, and safety interventions.

Dravet Syndrome Epidemiology Segmentation

DelveInsight's epidemiological model evaluates the Dravet syndrome patient population across the 7MM using the following segments:

  • Total Dravet Syndrome Diagnosed Prevalent Cases

  • Mutation-specific Diagnosed Prevalent Cases

  • Age-specific Diagnosed Prevalent Cases

  • Gender-specific Diagnosed Prevalent Cases

The total diagnosed prevalent population across the 7MM reached approximately 25,600 cases in 2025, with the United States accounting for approximately half of diagnosed cases. The epidemiological assessment also indicates that SCN1A mutations are associated with approximately 80–90% of Dravet syndrome cases, highlighting the importance of mutation-specific diagnosis and therapeutic development.

Current Dravet Syndrome Treatment Landscape

Treatment currently focuses primarily on reducing seizure frequency and severity, preventing prolonged seizures and status epilepticus, and managing developmental and behavioral complications. Combination anti-seizure therapy commonly involves agents such as valproate, clobazam, stiripentol, cannabidiol, and fenfluramine. Sodium-channel-blocking anti-seizure medications are generally avoided because they may worsen seizures in Dravet syndrome.

Among disease-specific marketed treatments, EPIDIOLEX/EPIDYOLEX (cannabidiol) is an oral therapy used for seizures associated with Dravet syndrome. FINTEPLA (fenfluramine) is another established treatment and is marketed in the United States, Europe, and Japan. DIACOMIT (stiripentol) is also an important component of the existing therapeutic landscape.

Non-pharmacological approaches, including the ketogenic diet, may be considered for selected patients. Rescue medication is important for prolonged seizures, while multidisciplinary care addresses developmental, cognitive, behavioral, and safety needs.

The emerging pipeline represents a potentially important transition from symptomatic treatment toward disease-modifying intervention, particularly through therapies designed to increase functional NaV1.1 expression or regulate SCN1A activity.

Unmet Needs in the Dravet Syndrome Market

Despite improvements in seizure management, substantial unmet needs remain. There is currently a need for therapies capable of addressing the underlying genetic cause of disease rather than primarily controlling seizures. Many patients continue to experience refractory seizures despite multidrug treatment, while developmental and behavioral comorbidities remain a major contributor to overall disease burden.

Additional challenges include treatment-related safety concerns, drug interactions, heterogeneous treatment response, chronic treatment burden, and limited therapeutic choices due to the need to avoid certain sodium-channel-blocking medications. Consequently, therapies capable of providing durable seizure control together with improvements in cognitive, developmental, behavioral, and motor outcomes could address a substantial unmet need.

Scope of the Dravet Syndrome Market Report

The report covers a study period from 2022 to 2036, with 2022–2025 as the historical period, 2026–2036 as the forecast period, and 2026 as the base year. Geographic coverage includes the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.

The report provides comprehensive coverage of:

  • Dravet syndrome epidemiology and patient-burden forecasts

  • Historical and forecasted market trends

  • Current treatment practices and treatment algorithms

  • Marketed and emerging therapy assessment

  • Drug uptake and market-share analysis

  • Competitive and clinical-development landscape

  • Market access and reimbursement

  • Pricing and analogue assessment

  • SWOT and conjoint analysis

  • Key opinion leader insights

  • Unmet needs and future market opportunities

To know more about Dravet Syndrome companies, clinical trials, and therapeutic assessment, request a sample @Dravet Syndrome Market Report Sample

Table of Contents

  1. Key Insights

  2. Report Introduction

  3. Executive Summary

  4. Key Events

  5. Epidemiology and Market Forecast Methodology

  6. Dravet Syndrome Market Overview at a Glance

  7. Dravet Syndrome Disease Background and Overview

  8. Dravet Syndrome Epidemiology and Patient Population

  9. Dravet Syndrome Current Treatment Practices

  10. Dravet Syndrome Marketed Therapies

  11. Dravet Syndrome Emerging Therapies

  12. Dravet Syndrome Drug Analysis and Competitive Landscape

  13. Dravet Syndrome Market Outlook

  14. Dravet Syndrome Market Size and Forecast

  15. Dravet Syndrome Drug Uptake Analysis

  16. Dravet Syndrome Market Access and Reimbursement

  17. Dravet Syndrome Pricing and Analogue Assessment

  18. Dravet Syndrome Unmet Needs

  19. KOL Views and Expert Insights

  20. SWOT and Conjoint Analysis

  21. Market Drivers and Barriers

  22. Appendix

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in the life sciences and healthcare industries. Founded in 2014, the company provides comprehensive market intelligence, epidemiology, and insights across pharmaceuticals, biotechnology, medical devices, and emerging therapies. DelveInsight helps healthcare organizations make informed strategic decisions through data-driven research and industry expertise.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kirti Sharma
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Mole Launches AI SEO & GEO Agent to Help Teams Rank on Google and ChatGPT

Mole Launches AI SEO & GEO Agent to Help Teams Rank on Google and ChatGPT
AI SEO Agent Mole Capabilities
Mole, an AI SEO & GEO Agent, has launched to help startups, agencies, and growth teams automate SEO research, page work, indexing, and review — without handing strategy to a bot. Mole assigns each client an isolated agent that turns company and customer context into SEO work a human reviews and approves, keeping the strategy and client relationship with the team.

SINGAPORE, October 07, 2026 — Mole, an AI SEO & GEO Agent, has launched to automate and expedite how teams execute their own search strategy across Google and AI engines like ChatGPT, Perplexity, and Claude.

Launched to its first cohort of startups and businesses on 21 September 2026, Mole assigns each client an isolated AI agent that starts from the company's own product and customer details, then turns that context into SEO work the team can review and build on. Rather than handing SEO to a "black box" bot, or reporting data that still leaves a human team to carry the work, Mole keeps the strategy, judgment, and client relationship with the team while the agent does the repetitive work at machine speed.

The launch arrives as search is no longer Google-only. Buyers now ask questions in ChatGPT and Google's AI Overviews, and companies with no presence in AI answers are losing qualified demand to competitors who show up there.

"Every AI SEO tool is racing toward the same pitch: 'let the machine run your SEO for you,'" said Raymond Yeh, founder of Synscribe, the agency behind Mole. "Mole goes the other way. The agent brings the research and does the grunt work at machine speed, but the strategy and the client stay yours. We built it because scaling clients shouldn't mean scaling headcount."

What Mole Does

Mole unifies three disciplines the industry has treated as separate silos — traditional SEO, Generative Engine Optimization (GEO), and Agentic Discovery — into a single agent composed of 18 capabilities, including Company Brain, AI Company Research and SEO Competitor Analysis, Keyword Extraction and Fan-Out Research, an AI SEO Content Writer and editor, an AI Landing Page Generator, and a Google Indexer alongside rank and AI-visibility tracking. Rather than a dashboard that only reports, Mole carries the work from research through review — with a human approving each step, and the strategy and client relationship staying with the team.

Proof in Practice

Mole is not a bench project — it is the platform Synscribe, a top SEO & GEO agency, actively uses to run search work for its clients. The agent's execution engine has produced results such as a brand-new site ranking on Google and being recommended by ChatGPT within 24 hours of launch.

"The fastest way to earn a founder's or an agency's trust isn't a promise — it's running real client work through the same agent you hand your own clients," Yeh said. "Mole is that engine, in the customer's hands."

Availability

Mole is available right now. Teams, founders, and agencies can request access at their website. The company offers the agent together with a SEO & GEO Course for Founders & Agencies that teaches the fundamentals and judgment needed to direct the agent.

About Synscribe

Mole is built by Synscribe, an SEO, GEO, and AI search optimization agency for B2B companies, run by a team of full-stack AI engineers and growth experts.

Media Contact
Company Name: Synscribe
Contact Person: Raymond
Email:Send Email
Phone: +6583186919
Country: Singapore
Website: https://synscribe.com/

SWIM Women's Success Club: From Credit to Capital book prepares women to connect financial education, business capital and entrepreneurship

SWIM Women's Success Club: From Credit to Capital book prepares women to connect financial education, business capital and entrepreneurship
SWIM: From Credit to Capital is a women-centered educational roadmap by Romeo Sykes and Cyra Gish covering financial preparation, business capital, entrepreneurship, ownership, operating infrastructure and greater financial choice. The book is expected to be available on Amazon and through Cyra Gish’s page.
SWIM announces a women-centered educational book examining how financial preparation, business capital, entrepreneurship, ownership and operating infrastructure can work together.

NEW YORK, NY - October 07, 2026 - SWIM — Successful Women Investing Money — is preparing the release of SWIM: From Credit to Capital, a women-centered educational book by Romeo Sykes and Cyra Gish examining the relationship between financial preparation, business capital, entrepreneurship, ownership, systems and long-term financial independence.

The publication is designed as an educational roadmap rather than a financing manual.

Information about Gish, SWIM, book availability and related business-capital discussions is available at https://nationwidebusinessfunding.com/cyrag.

The book is expected to be available through Amazon and through information provided on Gish’s page.

Why Credit to Capital is broader than borrowing

The title reflects a progression.

SWIM distinguishes among cash, credit and capital.

Cash is money already possessed.

Credit provides access to resources under repayment obligations.

Capital is broader and can include different resources deployed toward an economic objective.

That distinction allows the book to move beyond a narrow discussion of borrowing.

A legitimate business objective may require money, experienced people, operating systems, technology, professional relationships or some combination of resources.

The book therefore encourages readers to identify the economic objective before deciding whether outside financing belongs in the strategy.

“Capital should have a purpose before it has a product,” Gish said. “The educational goal is understanding why money may be needed, what obligations it creates and what must happen after it arrives.”

The book follows a progression toward ownership

SWIM: From Credit to Capital covers financial readiness, business structure, entrepreneurship, capital strategy, real estate, acquisitions, supported ownership, operating systems and financial wellness.

Ownership is treated separately from employment.

The book examines how a woman may participate in a business or asset while relying on management, administration, technology, fulfillment, sales systems or experienced operators to perform some functions.

SWIM describes this as supported ownership.

Supported ownership does not mean guaranteed passive income.

Someone remains responsible for operating the business, and transaction-specific rights and obligations should be documented appropriately.

Connecting education with real business questions

The book also examines a question frequently faced by entrepreneurs: whether every legitimate business objective must be funded entirely from personal savings.

Businesses often evaluate different capital sources depending on purpose, eligibility, timing and economics.

That does not mean outside financing is always appropriate.

SWIM encourages readers to examine cost, repayment obligations, timing, projected economics and downside risk.

The distinction between obtaining capital and deciding what capital should accomplish appears throughout the book.

Cyra Gish connects the book with women-owned businesses

Gish serves as SWIM New York Chapter President and works with Nationwide Business Funding.

Her role creates a connection between the book’s educational framework and real-world discussions with entrepreneurs and women-owned businesses evaluating legitimate commercial objectives.

Nationwide Business Funding operates separately from SWIM.

Qualified entrepreneurs may evaluate potential financing pathways through independent providers, while SWIM participation remains an educational and community relationship.

Independent providers control underwriting, approval and financing terms.

No purchase of the book and no SWIM participation guarantees financing.

Passing financial knowledge forward

Another theme in the book is the lineage of financial education.

Sykes describes learning from authors who influenced his own understanding before sharing selected books, ideas and concepts with Gish.

The process became part of SWIM’s philosophy: knowledge can move from author to reader, mentor to student and eventually from one woman to another.

Rather than presenting financial knowledge as a secret, SWIM presents it as information that can be studied, questioned, responsibly applied and passed forward.

Frequently Asked Questions

What is SWIM: From Credit to Capital?A women-centered educational roadmap covering capital, entrepreneurship, ownership, systems and financial wellness.

Who wrote the book?Romeo Sykes and Cyra Gish.

Will it be available on Amazon?Yes. The book is expected to be available through Amazon.

Does buying the book provide financing?No.

About SWIM

SWIM — Successful Women Investing Money — is a women-centered education and ownership community focused on entrepreneurship, capital, companies, assets, operating infrastructure and financial wellness. Its mission includes helping women understand financial preparation, business ownership and the resources that may support larger economic choices.

About Nationwide Business Funding

Nationwide Business Funding is a business-funding marketplace and capital-strategy organization helping qualified businesses evaluate potential financing through independent providers. Approval, amounts, rates, fees and terms remain subject to provider requirements.

Media Contact
Company Name: Nationwide Business Funding a Div. of LMT
Contact Person: Nationwide Business Funding
Email:Send Email
Phone: 1 (888) 599-8038
Address:1000 Brickell Ave
City: Miami
State: FL
Country: United States
Website: https://www.nationwidebusinessfunding.com